Original article can be found at: http://www.sciencedirect.com/science/journal/00142999 Copyright Elsevier B.V. DOI : 10.1016/j.ejphar.2006.04.015Peer reviewe

Baydoun, A. R.

Molleman, A.

Mormina, M. E.

Thakur, S.

Whelan, C.J.

European Journal of Pharmacology

English

The molecular events mediating the immunomodulatory properties of cannabinoids have remained largely unresolved. We have therefore investigated the molecular mechanism(s) through which R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl] pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-napthanlenyl) methanone (WIN55212-2) modulate production of interleukin-8 (IL-8) in HT-29 cells. Release of IL-8 induced by tumor necrosis factor-alpha (TNF-alpha) was determined by enzyme-linked immunosorbent assay (ELISA). Changes in expression of inhibitory kappa B (IkappaB) were monitored by Western blotting and activation of nuclear factor-kappa B (NF-kappaB) was determined in electrophoretic mobility shift assay (EMSAs). TNF-alpha induced release of IL-8 was inhibited by WIN55212-2 which also blocked the degradation of IkappaB-alpha and activation of NF-kappaB induced by TNF-alpha. These data provide strong evidence that WIN55212-2 may modulate IL-8 release by negatively regulating the signaling cascade leading to the activation of NF-kappaB. These findings highlight a potential mechanism for the immunomodulatory properties of cannabinoids and contribute towards acquiring a clear understanding of the role of cannabinoids in inflammation

Mormina, Maria E.

Thakur, Shori

Molleman, Areles

Whelan, Cliff J.

Baydoun, Anwar R.

University of East Anglia digital repository

Cannabinoid signalling in TNF-alpha induced IL-8 release

Crossref

University of Hertfordshire Research Archive

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.

A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.

Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

Attenuation of inducible nitric oxide synthase gene expression by D9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kB/Rel activation.

Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines.

Cannabinoid receptors and immunity.

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.

Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?

Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells.

Cannabinol mediated inhibition of nuclear factor kB, cAM response element binding protein, and interleukin-2 secretion by activated thymocytes.

Colonic epithelial cell lines as source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharides.

Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-α production by human mononuclear cells.

Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice.

Evidence for cannabinoid receptordependent and independent mechanisms of action in leukocytes.

Identification and characterization of an I kappa B kinase.

IKK-1 and IKK-2: Cytokine-activated I kappa B kinases essential for NF-kappa B activation.

Inhibition of adenylate cyclase by delta 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoidmediated immunosuppression. Life Sci.51,

Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties.

Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.

Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.

Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.

Inhibition of the cAMP signaling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds.

Inhibitory Effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine.

Modulation of CREB and NF-kB signal transduction by cannabinol in activated thymocytes.

NF-kappa B and rel proteins: Evolutionarily conserved mediators of immune responses.

NF-kappa B: a key role in inflammatory diseases.

Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.

Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol.

Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.

Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through downregulation of the nuclear factor of activated T cells.

Suppression of lymphocyte adenosine 3':5'-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol.

Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1betastimulated human astrocytes.

The I kappa B kinase complex (IKK) contains two kinase subunits, IKK alpha and IKK beta, necessary for I kappa B phosphorylation and NF-kappa B activation.

The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

Cannabinoid signalling in TNF-alpha induced IL-8 release

Abstract

Similar works

Full text

Available Versions

University of East Anglia digital repository

Crossref

University of Hertfordshire Research Archive